Pharma Mar SA header image

Pharma Mar SA

PHM

Equity

ISIN ES0169501022 / Valor 56130572

BME Bolsas y Mercados Espanoles - Renta Variable (2026-08-31)
EUR 81.35-1.75%

Pharma Mar SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Pharma Mar SA, headquartered in Madrid, Spain, is a biopharmaceutical company specializing in the development of oncology drugs derived from marine biodiversity. Established in 1986, the company has a strong focus on researching and developing treatments for rare cancers, leveraging the unique antitumor properties found in marine organisms. Pharma Mar commercializes three main drugs, which, through partnerships with 18 companies, are distributed in over 70 countries. The company has a significant international presence with subsidiaries in Germany, France, Italy, Belgium, Austria, Switzerland, and the United States. Pharma Mar is committed to reinvesting its profits and partner revenues into research and development, as well as the continuous training of its team, to advance its mission of providing innovative cancer therapies.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

0.06%1Y
128%3Y
11.5%5Y

Performance

44.5%1Y
43.4%3Y
42.5%5Y

Volatility

Market cap

1635 M

Market cap (USD)

Daily traded volume (Shares)

45,068

Daily traded volume (Shares)

1 day high/low

80.05 / 76.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%USD 74.18
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.63%USD 64.34
DBV Technologies SA
DBV Technologies SA DBV Technologies SA Valor: 2857349
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 2.37
Medios AG
Medios AG Medios AG Valor: 19069483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.45%EUR 11.18
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.17%USD 4.50
Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc Valor: 10773079
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.91%USD 4.25
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc Valor: 25337263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.97%USD 106.13
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%USD 389.41
Merck & Co Inc
Merck & Co Inc Merck & Co Inc Valor: 10683053
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.40%USD 147.76
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.55%CHF 63.50